This letter describes the heteroepitaxy of InP on Si by MOCVD. A new epitaxial structure with a thin GaAs intermediate layer (InP/GaAs/Si) is proposed to alleviate the large lattice mismatch (8.4%) between InP and Si. Using this structure, a 4-inch InP single crystal with a mirror-like surface and good thickness uniformity (Δd/d=±10%) was obtained. Residual stress in the InP film was 5.7±108 dyn/ cm2 for the InP/GaAs/Si structure, as compared to 8.3×108 dyn/cm2 for the InP directly grown on Si. This shows that the GaAs intermediate layer is also effective in reducing the residual stress in the InP epilayer.
Epitaxial single crystal growth of zirconia (ZrO2) and yttria stabilized zirconia (ZrO2 ·Y2O3) films on sapphire substrates was achieved for the first time by using reactive sputtering. And the relations of crystallographic orientations between the epitaxial films and sapphire substrates was determined. Yttria stabilized zirconia films seem to offer hiah quality SOI substrates, since the crystal structure of ZrO2·Y2O3 is cubic fluorite and its lattice constant is closely matched to those of semiconductors such as Si and GaAs.
The heteroepitaxy of InP on Si substrates was investigated using MOCVD. A thin GaAs intermediate layer was used to alleviate the 8.4% lattice mismatch between InP and Si. With the use of this intermediate layer, four inch size, single domain InP epilayer with small residual stress was reproducibly grown on off-(100) oriented Si substrates. The etch pit density (EPD) of as-grown InP layer was 5x107~1x108 cm-2 . The post growth annealing of this epilayer at 800~850ºC in aPH3+H2 ambient reduced EPD to 1~2x107 cm-2
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.